Serious complications of low weight molecular heparins-five clinical case rep

Authors

  • Filipa Aragão Carvalho Interna do Internato Complementar de Medicina Interna, Serviço de Medicina II e Unidade de Pneumologia do Hospital Fernando Fonseca, Amadora
  • Sofia Ravara Assistente de Pneumologia, Serviço de Medicina II e Unidade de Pneumologia do Hospital Fernando Fonseca, Amadora
  • Fernanda Martins Assistente Graduada de Medicina Interna, Serviço de Medicina II e Unidade de Pneumologia do Hospital Fernando Fonseca, Amadora
  • Luís Dutschmann Director de Serviço Serviço de Medicina II do Hospital Fernando Fonseca, Amadora

Keywords:

deep venous trombosis venous, pulmonary thromboembolism, low weight molecular heparin, bleeding

Abstract

During a two year period the authors detected haemorrhagic complications of low weight
molecular heparin´s(LWMH) in five patients: 3 females and 2 males with an average age greater than 75.
LMWH was used in deep vein thrombosis/ pulmonary thromboembolism (DVT/PTE) suspicion (2), unstable angina (1) and DVT/PTE
prevention (2). Adverse effects were spontaneous retroperitoneal bleeding with hypovolaemic shock (1), haemorrhagic suffusion with intramuscular haematoma (1), extensive per umbilical haematoma (1) and haemorrhagic
suffusions (2). As reported, additional risk factors for bleeding are: old age, chronic renal
insuficiency, chronic hepatic disease, use of salicylates and systemic corticotherapy.
The authors concluded that patients undergoing continuous LMWH therapy should be criteriously identified and monitorized to prevent complications

Downloads

Download data is not yet available.

References

Sarret M, Kher A, Toulemonde F. Low molecular weight heparin therapy – an evaluation of clinical trials evidence. New York: Marcel

Dekker 1999.

Lugassy G, Brenner B, Schulman S, Samama M, Cohen M. Thrombosisand Antithrombotic Therapy. London: Martin Dunitz 2001.

Dutschman L. Heparinas de baixo peso molecular: que utilidade terapêutica?. Medicina Interna 1994; 1(2): 120.

Dabney A, Bastani B. Enoxaparin-associated severe retroperitoneal bleeding and abdominal compartment syndrome: a report of two cases.

Intensive care Med 2001; 27: 1954-1957.

Findik S, Erken ML. Low molecular weight heparin vs UFH in treatment of patients with pulmonary thromboembolism. Respiration 2002;

(5): 440-444.

Boneu B, de Moerloose P. How and when to monitor a patient treated with low molecular weight heparin. Semin Thromb Hemost 2001;

(5):519-522.

Bonnet F, Morlat P, de Witte S, Bernard N, Lacoste D, Beylot J. Hemorrhagic accidents with low molecular weight heparin: 15 cases. Rev

Med Interne 2001; 22(8): 761-763

Additional Files

Published

2004-03-31

How to Cite

1.
Aragão Carvalho F, Ravara S, Martins F, Dutschmann L. Serious complications of low weight molecular heparins-five clinical case rep. RPMI [Internet]. 2004 Mar. 31 [cited 2024 May 18];11(1):45-8. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/1726

Issue

Vol. 11 No. 1 (2004): Janeiro/ Março

Section

Review Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Medicina Interna

Open Access

Most read articles by the same author(s)

<< < 1 2